Indegene IPO: The initial public offering of healthcare tech firm Indegene Ltd is now open for subscription. At the time of filing this report, the Indegene IPO subscription status is 1.50 times, as per the NSE data. The three-day initial public offering will conclude on Wednesday i.e. May 8. 

Indegene IPO: Anil Singhvi's view

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

Zee Business Managing Editor Anil Singhvi on Monday recommended investors to apply in Indegene IPO for big listing gain. Singhvi said that investors must keep the long-term objective in this offer.

"We are having such an IPO after a long time. It was very tough to find out negatives in this IPO. This IPO is good for listing gain and long-term investment. They have a strong anchor book and I am confident that this IPO will get a very good response," Singhvi said.

Indegene IPO: Positives

- Experienced promoters

- Strong business model

- Impressive growth track record

- Attractive valuations

Indegene IPO: Negatives

- 96 per cent of business only from North America and Europe

- Focuses only on the life science industry

Indegene IPO: Here are important details that investors must know

Indegene IPO subscription open date 

The initial share-sale offer of Indegene opens for public subscription on May 6.

Indegene IPO subscription end date 

The subscription for Indegene IPO will open for three days and will end on May 8.

Indegene IPO price range

The healthcare tech firm that caters to the Life Sciences industry has a fixed price band for the upcoming IPO at Rs 430 to Rs 452 apiece.

Indegene IPO lot size

The minimum lot size for an application is 33 shares. At the upper price band, the minimum amount of investment required by retail investors is Rs 14,916. 

Indegene IPO allotment date

According to the information available, the likely date for the allotment of shares is May 9 2024.

Indegene IPO registrar

Link Intime India Private Limited has been appointed as the official registrar of Indegene IPO.

Indegene IPO book running lead managers

Kotak Mahindra Capital, Citigroup Global Markets India, J P Morgan India, Nomura Financial Advisory and Securities (India) are the book-running lead managers to the issue.

Indegene IPO listing

The shares of Indegene are expected to be listed on BSE and NSE.

Indegene IPO listing date

The IPO is expected to follow the 'T+3 listing rule' and shares of the company are expected to list on bourses on May 13 2024.